Address : 345 Park Avenue South, New York, United States
Phone Number : +1 (646) 844-0337
Industries : Research
Website : protaratx.com
Protara is committed to advancing transformative therapies for people with cancer and rare diseases. Protara's portfolio includes its lead program, TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational, intravenous phospholipid substrate replacement therapy in development for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.
Employees Total : 50
Revenue (Yearly) : 200K
Total Funding : 151.8M
Latest Funding : 4.2M
Public Company : Yes
Trade Symbol : TARA
Trade Exchange : Nasdaq
Market Cap : 200K
Founded in : 2017
Twitter : proteontx
Linkedin : protara-therapeutics
Email Providers : Outlook
Recruitment : Greenhouse.io
Fonts : Typekit
Web Performance Monitoring : New Relic
CMS : WordPress.org
Tag Management : Google Tag Manager
Last Updated : 2023-12-05
Progenics Pharmaceuticals, Inc. New York, United States Research |
Intercept Pharmaceuticals Morristown, New Jersey, United States Pharmaceuticals |
Delta Upsilon International Fraternity Indianapolis, Indiana, United States Nonprofit Organization Management |
Talal Abu-Ghazaleh Global Amman, Jordan Information Technology & Services |
LARICO INFRASTRUCTURE SDN BHD Petaling Jaya, Selangor, Malaysia Construction |
Rodan and Fields, Personal Skin care Consultant Rockville Centre, New York, United States Health, Wellness & Fitness |